NCT03223298 - Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2018

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions

Pain, HeadPain SyndromeTemporomandibular DisorderMyofascial Pain SyndromeMyofascial Pain

Interventions

DRUG

Botulinum toxin type A

37.5 units injected into each masseter muscle and 12.5 units into each temporalis muscle

DRUG

0.9% Sodium Chloride Injection

1cc syringe

Trial Locations (2)

Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York

University of Illinois at Chicago, Chicago